[HTML][HTML] Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations
…, PJ de Vries, MD Frost, Z Fuchs, ES Gosnell, N Gupta… - Pediatric Neurology, 2021 - Elsevier
Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …
Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management
FX McCormack, N Gupta, GR Finlay… - American journal of …, 2016 - atsjournals.org
Background: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that primarily
affects women. The purpose of these guidelines is to provide recommendations for the …
affects women. The purpose of these guidelines is to provide recommendations for the …
Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management
Lymphangioleiomyomatosis (LAM) is a slowly progressive, low-grade, metastasising neoplasm
of women, characterised by infiltration of the lung parenchyma with abnormal smooth …
of women, characterised by infiltration of the lung parenchyma with abnormal smooth …
Landslide susceptibility zonation through ratings derived from artificial neural network
In the present study, Artificial Neural Network (ANN) has been implemented to derive
ratings of categories of causative factors, which are then integrated to produce a landslide …
ratings of categories of causative factors, which are then integrated to produce a landslide …
Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management …
N Gupta, GA Finlay, RM Kotloff, C Strange… - American journal of …, 2017 - atsjournals.org
Background: Recommendations regarding key aspects related to the diagnosis and
pharmacological treatment of lymphangioleiomyomatosis (LAM) were recently published. We now …
pharmacological treatment of lymphangioleiomyomatosis (LAM) were recently published. We now …
[HTML][HTML] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
…, L Chung, RT Domsic, KR Flaherty, N Gupta… - Respiratory …, 2023 - Springer
Background Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder. Interstitial
lung disease (ILD) is common in SSc, occurring in 35–52% of patients and accounting for …
lung disease (ILD) is common in SSc, occurring in 35–52% of patients and accounting for …
Diffuse cystic lung disease. Part I
N Gupta, R Vassallo… - American journal of …, 2015 - atsjournals.org
The diffuse cystic lung diseases (DCLDs) are a group of pathophysiologically heterogenous
processes that are characterized by the presence of multiple spherical or irregularly shaped, …
processes that are characterized by the presence of multiple spherical or irregularly shaped, …
Diffuse cystic lung disease. Part II
N Gupta, R Vassallo… - American journal of …, 2015 - atsjournals.org
The diffuse cystic lung diseases have a broad differential diagnosis. A wide variety of
pathophysiological processes spanning the spectrum from airway obstruction to lung remodeling …
pathophysiological processes spanning the spectrum from airway obstruction to lung remodeling …
Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: the ISABELA 1 and 2 randomized clinical trials
…, J Fitzgerald, DG Manjarres, M Gotfried, N Gupta… - Jama, 2023 - jamanetwork.com
Importance There is a major need for effective, well-tolerated treatments for idiopathic
pulmonary fibrosis (IPF). Objective To assess the efficacy and safety of the autotaxin inhibitor …
pulmonary fibrosis (IPF). Objective To assess the efficacy and safety of the autotaxin inhibitor …
Bioavailability enhancement of curcumin by complexation with phosphatidyl choline
NK Gupta, VK Dixit - Journal of pharmaceutical sciences, 2011 - Elsevier
Curcumin is a major constituent of rhizomes of Curcuma longa. Pharmacokinetic studies of
curcumin reveal its poor absorption through intestine. Objective of the present study was to …
curcumin reveal its poor absorption through intestine. Objective of the present study was to …